Arthur M. Blank Hospital- Children's Healthcare of Atlanta

Atlanta, Georgia 30329

2 studies enrolling now · 2 studies all time

What they study most

Hemophilia B, Sickle Cell Disease

Studies at this site

• Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B — Recruiting now
• Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD) — Recruiting now